Stinging nettle extract inhibits SARS-CoV-2 cell fusion

Belgique Nouvelles Nouvelles

Stinging nettle extract inhibits SARS-CoV-2 cell fusion
Belgique Dernières Nouvelles,Belgique Actualités
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 71%

Stinging nettle extract inhibits SARS-CoV-2 cell fusion Cell SARSCoV2 Coronavirus Disease COVID CellFusion biorxivpreprint KU_Leuven UGent

Study: Carbohydrate-Binding Protein from Stinging Nettle as Fusion Inhibitor for SARS-CoV-2 Variants of Concern. Image Credit: Craig Walton / Shutterstock

UDA selectively hinders the replication of numerous viruses, including coronaviruses, in different cell kinds. Prior studies with respiratory syncytial virus , human immunodeficiency virus , and influenza virus demonstrated that UDA impedes viral entry, possibly by blocking virus fusion. Initially, the plant lectin UDA was assessed against pseudotyped SARS-CoV-2. Subsequently, the antiviral effectiveness of UDA was examined against the wild-type virus. The team also evaluated UDA against the SARS-CoV-2 Omicron and Delta VOCs.

Results and conclusions The study results indicated that in A549 angiotensin-converting enzyme 2 transmembrane protease serine 2 cells, UDA effectively prevents entry of pseudotyped SARS-CoV-2 with half-maximal inhibitory concentration values varying from 0.32 to 1.22 microM.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

NewsMedical /  🏆 19. in UK

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

SARS-CoV-2 spike protein downregulates ACE2 expressionSARS-CoV-2 spike protein downregulates ACE2 expressionSARS-CoV-2 spike protein downregulates ACE2 expression SARSCoV2 COVID19 ACE2 SpikeProtein
Lire la suite »

A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge - Nature CommunicationsA broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge - Nature CommunicationsSARS-CoV-2 variants of concern such as the Omicron variant pose a challenge for vaccination and antibody immunotherapy. Here, Zhou et al. isolate a broadly neutralizing antibody (bNAb), named ZCB11, that protects Golden Syrian hamsters against Omicron. Applying CryoEM the authors show that ZCB11 heavy chain predominantly interacts with RBD in up confirmation, which interferes with ACE2 receptor binding.
Lire la suite »

SARS-CoV-2 spike protein downregulates ACE2 expressionSARS-CoV-2 spike protein downregulates ACE2 expressionSARS-CoV-2 spike protein downregulates ACE2 expression SARSCoV2 COVID19 ACE2 SpikeProtein
Lire la suite »

Pregnant women at increased risk of COVID-19 severityPregnant women at increased risk of COVID-19 severityPregnant women at increased risk of COVID-19 severity UofT SARSCoV2 COVID19 COVIDSeverity Pregnancy
Lire la suite »

A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge - Nature CommunicationsA broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge - Nature CommunicationsSARS-CoV-2 variants of concern such as the Omicron variant pose a challenge for vaccination and antibody immunotherapy. Here, Zhou et al. isolate a broadly neutralizing antibody (bNAb), named ZCB11, that protects Golden Syrian hamsters against Omicron. Applying CryoEM the authors show that ZCB11 heavy chain predominantly interacts with RBD in up confirmation, which interferes with ACE2 receptor binding.
Lire la suite »

Immune response after mild COVIDImmune response after mild COVIDIn a recent study posted to the medRxiv* preprint server, researchers in Germany assessed the immunity elicited by a mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Lire la suite »



Render Time: 2025-04-10 15:48:33